Literature DB >> 36268253

Advancing proteomics and machine learning in the clinic: an editorial on "Noninvasive proteomic biomarkers for alcohol-related liver disease".

Courtney D McGinnis1, Brenton I M Graham1, Peter S Harris1, Kristofer S Fritz1.   

Abstract

Entities:  

Year:  2022        PMID： 36268253      PMCID： PMC9577981          DOI： 10.21037/hbsn-22-390

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN： 2304-3881            Impact factor:   8.265


× No keyword cloud information.
  11 in total

1.  Alcoholic liver disease: from pathophysiology to therapy.

Authors:  Helmut K Seitz; Charles S Lieber; Felix Stickel; Mikko Salaspuro; Hans-Peter Schlemmer; Yoshimori Horie
Journal:  Alcohol Clin Exp Res       Date:  2005-07       Impact factor: 3.455

Review 2.  Therapy for alcoholic liver disease.

Authors:  Maryconi M Jaurigue; Mitchell S Cappell
Journal:  World J Gastroenterol       Date:  2014-03-07       Impact factor: 5.742

Review 3.  Current trials and novel therapeutic targets for alcoholic hepatitis.

Authors:  Ashwani K Singal; Vijay H Shah
Journal:  J Hepatol       Date:  2019-02       Impact factor: 25.083

Review 4.  Research methodologies to address clinical unmet needs and challenges in alcohol-associated liver disease.

Authors:  Ashwani K Singal; Paul Kwo; Allison Kwong; Suthat Liangpunsakul; Alexandre Louvet; Pranoti Mandrekar; Craig McClain; Jessica Mellinger; Gyongyi Szabo; Norah Terrault; Mark Thursz; Gerald S Winder; W Ray Kim; Vijay H Shah
Journal:  Hepatology       Date:  2021-11-27       Impact factor: 17.298

5.  Noninvasive proteomic biomarkers for alcohol-related liver disease.

Authors:  Lili Niu; Maja Thiele; Philipp E Geyer; Ditlev Nytoft Rasmussen; Henry Emanuel Webel; Alberto Santos; Rajat Gupta; Florian Meier; Maximilian Strauss; Maria Kjaergaard; Katrine Lindvig; Suganya Jacobsen; Simon Rasmussen; Torben Hansen; Aleksander Krag; Matthias Mann
Journal:  Nat Med       Date:  2022-06-02       Impact factor: 87.241

6.  Proteomic analysis of alcohol-associated hepatitis reveals glycoprotein NMB (GPNMB) as a novel hepatic and serum biomarker.

Authors:  Peter S Harris; Cole R Michel; Youngho Yun; Courtney D McGinnis; Mohammed A Assiri; Ali Reza Ahmadi; Zhaoli Sun; James R Roede; Matthew A Burchill; David J Orlicky; Rebecca L McCullough; Kristofer S Fritz
Journal:  Alcohol       Date:  2021-12-17       Impact factor: 2.558

7.  Integrated Multiomics Reveals Glucose Use Reprogramming and Identifies a Novel Hexokinase in Alcoholic Hepatitis.

Authors:  Veronica Massey; Austin Parrish; Josepmaria Argemi; Montserrat Moreno; Aline Mello; Mar García-Rocha; Jose Altamirano; Gemma Odena; Laurent Dubuquoy; Alexandre Louvet; Carlos Martinez; Anna Adrover; Silvia Affò; Oriol Morales-Ibanez; Pau Sancho-Bru; Cristina Millán; Edilmar Alvarado-Tapias; Dalia Morales-Arraez; Juan Caballería; Jelena Mann; Sheng Cao; Zhaoli Sun; Vijay Shah; Andrew Cameron; Phillipe Mathurin; Natasha Snider; Càndid Villanueva; Timothy R Morgan; Joan Guinovart; Rajanikanth Vadigepalli; Ramon Bataller
Journal:  Gastroenterology       Date:  2020-12-10       Impact factor: 33.883

Review 8.  Liver specific, systemic and genetic contributors to alcohol-related liver disease progression.

Authors:  Bernd Schnabl; Gavin E Arteel; Felix Stickel; Jan Hengstler; Nachiket Vartak; Ahmed Ghallab; Steven Dooley; Yujia Li; Robert F Schwabe
Journal:  Z Gastroenterol       Date:  2022-01-18       Impact factor: 1.769

Review 9.  Organ-Organ Crosstalk and Alcoholic Liver Disease.

Authors:  Lauren G Poole; Christine E Dolin; Gavin E Arteel
Journal:  Biomolecules       Date:  2017-08-16

Review 10.  Emerging Noninvasive Biomarkers, and Medical Management Strategies for Alcoholic Hepatitis: Present Understanding and Scope.

Authors:  Khushboo S Gala; Vatsalya Vatsalya
Journal:  Cells       Date:  2020-02-25       Impact factor: 6.600
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.